Use of insurance claims data to assess outpatient antimicrobial therapy for gram-positive infections

Yehuda Carmeli*, Essy Mozaffari

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

With the increasing frequency of antibiotic-resistant gram-positive infections in the United States, many patients are being treated outside the hospital setting. The majority of studies on the cost of outpatient antimicrobial therapy involve retrospective medical record review or prospective data collection. These methods tend to be expensive and time consuming, and often fail to produce a sufficiently large sample size. Analysis of insurance claims data offers a convenient approach for studying the costs associated with outpatient therapy for gram-positive infections. To demonstrate this approach, a study of the cost of intravenous vancomycin home care therapy was conducted using claims data from a large insurance company.

Original languageEnglish
Pages (from-to)55S-62S
JournalPharmacotherapy
Volume22
Issue number2 II
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Use of insurance claims data to assess outpatient antimicrobial therapy for gram-positive infections'. Together they form a unique fingerprint.

Cite this